Commentary: Contemporary Outcomes of Endovascular Interventions for Peripheral Artery Disease: The LIBERTY to Determine Optimal Treatment Strategies

Abstract

Keywords

atherectomy balloon angioplasty claudication critical limb ischemia endovascular therapy femoropopliteal segment infrapopliteal arteries peripheral artery disease quality of life stent

Get full access to this article

View all access options for this article.

References

El-Sayed

Bennett

Loh

Davies

. Retrograde pedal access and endovascular revascularization: a safe and effective technique for high-risk patients with complex tibial vessel disease. Ann Vasc Surg. 2016;31:91–98.

Walker

Mustapha

Zeller

et al . Tibiopedal access for crossing of infrainguinal artery occlusions: a prospective multicenter observational study. J Endovasc Ther. 2016;23:839–846.

Dayama

Tsilimparis

Kolakowski

et al . Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease. J Vasc Surg. 2019;69:156–163.

Goodney

Beck

Nagle

et al . National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54–60.

Katib

Thomas

Lennox

et al . An endovascular-first approach to the treatment of critical limb ischemia results in superior limb salvage rates. J Endovasc Ther. 2015;22:473–481.

Agarwal

Sud

Shishehbor

. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients. J Am Coll Cardiol. 2016;67:1901–1913.

Mustapha

Gray

Martinsen

et al . One-year results of the LIBERTY 360 Study: evaluation of acute and midterm clinical outcomes of peripheral endovascular device interventions. J Endovasc Ther. 2019;26:143–154.

Dormandy

Rutherford

. Management of peripheral arterial disease (PAD). TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1 pt 2):S1–S296.

Stavroulakis

Borowski

Torsello

et al ; CRITISCH Collaborators. One-year results of first-line treatment strategies in patients with critical limb ischemia (CRITISCH Registry). J Endovasc Ther. 2018;25:320–329.

10.

Vascular Quality Initiative. Improving vascular care through the VQI. https://vascular.org/research-quality/vascular-quality-initiative . Accessed January 26, 2019.

11.

American College of Cardiology’s PVI Registry. https://cvquality.acc.org/NCDR-Home/registries/hospital-registries/pvi-registry . Accessed January 26, 2019.

12.

Jones

Krucoff

Morales

et al . Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements. J Vasc Surg. 2018;67:637–644.e30.

13.

Schneider

Laird

Tepe

et al . Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT randomized SFA trial. Circ Cardiovasc Interv. 2018;11:e005891. doi:10.1161/CIRCINTERVENTIONS.117.005891

14.

Krishnan

Faries

Niazi

et al . Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies. Circulation. 2017;136:1102–1113.

15.

Gray

Keirse

Soga

et al . A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention. Lancet. 2018;392:1541–1551.

16.

Anand

Bosch

Eikelboom

et al . Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomized, double-blind, placebo-controlled trial. Lancet. 2018;391:219–229.

17.

Westin

Armstrong

Bang

et al . Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival rates in patients with critical limb ischemia. J Am Coll Cardiol. 2014;63:682–690.